The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) on Tuesday deliberated upon Hyderabad-based Bharat Biotech's application seeking permission to conduct phase II/III clinical trials to evaluate the safety, reactogenicity and immunogenicity of Covaxin jabs in children aged 2 to 18 years.
https://ift.tt/eA8V8J The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) on Tuesday deliberated upon Hyderabad-based Bharat Biotech's application seeking permission to conduct phase II/III clinical trials to evaluate the safety, reactogenicity and immunogenicity of Covaxin jabs in children aged 2 to 18 years. from Zee News :India National https://ift.tt/3o8FPAA
Bharat Biotech`s Covaxin gets approval for phase 2/3 trials on 2-18 year-olds
This is enroy and currently working with an IT firm based in Noida. And I love to search out new thing. Whether its place or a thing.
My Main Motive to Create this blogging site is to Promote Mostly Indian Brands and Boycott #Chinese Products. This is just small step to make india self dependent.
I am not saying that my shopping platform will not have Imported Brand but it certainly don't have Chinese Brand.
No comments:
Post a Comment